These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 14555316
1. The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis. Castaman G, Faioni EM, Tosetto A, Bernardi F. Haematologica; 2003 Oct; 88(10):1182-9. PubMed ID: 14555316 [Abstract] [Full Text] [Related]
3. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden. Otrock ZK, Taher AT, Shamseddeen WA, Zaatari G, Bazarbachi A, Mahfouz RA. Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780 [Abstract] [Full Text] [Related]
5. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile. Margaglione M, Bossone A, Coalizzo D, D'Andrea G, Brancaccio V, Ciampa A, Grandone E, Di MG. Thromb Haemost; 2002 Jan; 87(1):32-6. PubMed ID: 11848454 [Abstract] [Full Text] [Related]
6. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis. Kostka H, Schwarz T, Schellong S, Mix C, Kuhlisch E, Temelkova-Kurktschiev T, Henkel E, Köhler C, Gehrisch S, Siegert G. Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728 [Abstract] [Full Text] [Related]
7. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Folsom AR, Cushman M, Tsai MY, Aleksic N, Heckbert SR, Boland LL, Tsai AW, Yanez ND, Rosamond WD. Blood; 2002 Apr 15; 99(8):2720-5. PubMed ID: 11929758 [Abstract] [Full Text] [Related]
8. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia. Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, Heis N, Castaman G, Missiaglia E, Lechner K, Rodeghiero F. Am J Hematol; 2002 Sep 15; 71(1):1-6. PubMed ID: 12221665 [Abstract] [Full Text] [Related]
9. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden. Medina P, Navarro S, Estellés A, Vayá A, Bertina RM, España F. Thromb Haemost; 2005 Aug 15; 94(2):389-94. PubMed ID: 16113830 [Abstract] [Full Text] [Related]
15. Factor-V HR2 haplotype and thromboembolic disease. Aleksova A, Di Nucci M, Gobbo M, Bevilacqua E, Pradella P, Salam K, Barbati G, De Luca A, Mascaretti L, Sinagra G. Acta Cardiol; 2015 Dec 15; 70(6):707-11. PubMed ID: 26717220 [Abstract] [Full Text] [Related]
16. Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders. Strey RF, Siegemund A, Siegemund T, Schubert C, Schuster G, Wulff K, Herrmann FH. Pathophysiol Haemost Thromb; 2005 Dec 15; 34(6):279-83. PubMed ID: 16772740 [Abstract] [Full Text] [Related]
17. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene. Castaman G, Ruggeri M, Tosetto A, Rodeghiero F. Thromb Haemost; 2000 Aug 15; 84(2):357-8. PubMed ID: 10959717 [No Abstract] [Full Text] [Related]